Search

Scott Long

Examiner (ID: 10754, Phone: (571)272-9048 , Office: P/1633 )

Most Active Art Unit
1633
Art Unit(s)
1633
Total Applications
882
Issued Applications
557
Pending Applications
29
Abandoned Applications
301

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15145003 [patent_doc_number] => 20190350979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => UNDIFFERENTIATED STEM CELL REMOVAL AGENT AND METHOD FOR REMOVING UNDIFFERENTIATED STEM CELLS [patent_app_type] => utility [patent_app_number] => 16/468951 [patent_app_country] => US [patent_app_date] => 2017-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18740 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16468951 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/468951
UNDIFFERENTIATED STEM CELL REMOVAL AGENT AND METHOD FOR REMOVING UNDIFFERENTIATED STEM CELLS Dec 13, 2017 Abandoned
Array ( [id] => 13325971 [patent_doc_number] => 20180214523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => INJECTION SOLUTION FOR RNA [patent_app_type] => utility [patent_app_number] => 15/835403 [patent_app_country] => US [patent_app_date] => 2017-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15289 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15835403 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/835403
INJECTION SOLUTION FOR RNA Dec 6, 2017 Abandoned
Array ( [id] => 12764446 [patent_doc_number] => 20180146650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-31 [patent_title] => MMTV-SV40-Spy1A and Spy1A-pTRE Transgenic Mouse Models [patent_app_type] => utility [patent_app_number] => 15/823036 [patent_app_country] => US [patent_app_date] => 2017-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8009 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15823036 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/823036
MMTV-SV40-Spy1A and Spy1A-pTRE transgenic mouse models Nov 26, 2017 Issued
Array ( [id] => 12886036 [patent_doc_number] => 20180187187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => SELF-ASSEMBLING MOLECULAR NANOSYSTEM FOR TARGETED DNA AND GENE DELIVERY [patent_app_type] => utility [patent_app_number] => 15/821559 [patent_app_country] => US [patent_app_date] => 2017-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4213 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821559 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/821559
SELF-ASSEMBLING MOLECULAR NANOSYSTEM FOR TARGETED DNA AND GENE DELIVERY Nov 21, 2017 Abandoned
Array ( [id] => 18012153 [patent_doc_number] => 11504427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-22 [patent_title] => Acoustic and ultrasound-based mechanogenetics and thermogenetics for immunotherapy [patent_app_type] => utility [patent_app_number] => 16/463316 [patent_app_country] => US [patent_app_date] => 2017-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 12990 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 396 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463316 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/463316
Acoustic and ultrasound-based mechanogenetics and thermogenetics for immunotherapy Nov 21, 2017 Issued
Array ( [id] => 12880723 [patent_doc_number] => 20180185416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING HIV [patent_app_type] => utility [patent_app_number] => 15/816454 [patent_app_country] => US [patent_app_date] => 2017-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4962 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15816454 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/816454
METHODS AND COMPOSITIONS FOR TREATING HIV Nov 16, 2017 Abandoned
Array ( [id] => 12657139 [patent_doc_number] => 20180110879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-26 [patent_title] => SMOOTH MUSCLE SPECIFIC INHIBITION FOR ANTI-RESTENOTIC THERAPY [patent_app_type] => utility [patent_app_number] => 15/806007 [patent_app_country] => US [patent_app_date] => 2017-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15806007 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/806007
Smooth muscle specific inhibition for anti-restenotic therapy Nov 6, 2017 Issued
Array ( [id] => 12724282 [patent_doc_number] => 20180133261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-17 [patent_title] => TREATMENT OF PAIN USING PLACENTAL STEM CELLS [patent_app_type] => utility [patent_app_number] => 15/801318 [patent_app_country] => US [patent_app_date] => 2017-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15801318 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/801318
TREATMENT OF PAIN USING PLACENTAL STEM CELLS Oct 31, 2017 Abandoned
Array ( [id] => 16861770 [patent_doc_number] => 11020492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-01 [patent_title] => Gene correction of SCID-related genes in hematopoietic stem and progenitor cells [patent_app_type] => utility [patent_app_number] => 16/346237 [patent_app_country] => US [patent_app_date] => 2017-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21971 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346237 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/346237
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells Oct 30, 2017 Issued
Array ( [id] => 12601524 [patent_doc_number] => 20180092338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-05 [patent_title] => GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE [patent_app_type] => utility [patent_app_number] => 15/793901 [patent_app_country] => US [patent_app_date] => 2017-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55768 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15793901 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/793901
Genetically modified cells, tissues, and organs for treating disease Oct 24, 2017 Issued
Array ( [id] => 16058723 [patent_doc_number] => 10688285 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-23 [patent_title] => Spinal subpial gene delivery system [patent_app_type] => utility [patent_app_number] => 15/790477 [patent_app_country] => US [patent_app_date] => 2017-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 80 [patent_no_of_words] => 17201 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15790477 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/790477
Spinal subpial gene delivery system Oct 22, 2017 Issued
Array ( [id] => 17602911 [patent_doc_number] => 11331380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Cereblon-based heterodimerizable chimeric antigen receptors [patent_app_type] => utility [patent_app_number] => 16/343375 [patent_app_country] => US [patent_app_date] => 2017-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17968 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343375 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/343375
Cereblon-based heterodimerizable chimeric antigen receptors Oct 18, 2017 Issued
Array ( [id] => 13124881 [patent_doc_number] => 10080353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-25 [patent_title] => Porcine reproductive and respiratory syndrome virus resistant animals [patent_app_type] => utility [patent_app_number] => 15/783417 [patent_app_country] => US [patent_app_date] => 2017-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13729 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15783417 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/783417
Porcine reproductive and respiratory syndrome virus resistant animals Oct 12, 2017 Issued
Array ( [id] => 15496267 [patent_doc_number] => 20200048322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-13 [patent_title] => T CELLS EXPRESSING MEMBRANE-ANCHORED IL-12 FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 16/339691 [patent_app_country] => US [patent_app_date] => 2017-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24076 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -99 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339691 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/339691
T cells expressing membrane-anchored IL-12 for the treatment of cancer Oct 5, 2017 Issued
Array ( [id] => 16321497 [patent_doc_number] => 10781453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-22 [patent_title] => Non-human animals having a hexanucleotide repeat expansion in a C9ORF72 locus [patent_app_type] => utility [patent_app_number] => 15/721517 [patent_app_country] => US [patent_app_date] => 2017-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 37286 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721517 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/721517
Non-human animals having a hexanucleotide repeat expansion in a C9ORF72 locus Sep 28, 2017 Issued
Array ( [id] => 12580719 [patent_doc_number] => 20180085402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => COMPOSITIONS AND METHODS RELATED TO MULTIMODAL THERAPEUTIC CELL SYSTEMS FOR CANCER INDICATIONS [patent_app_type] => utility [patent_app_number] => 15/716141 [patent_app_country] => US [patent_app_date] => 2017-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27047 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15716141 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/716141
Compositions and methods related to engineered erythoid cells comprising 4-1BBL Sep 25, 2017 Issued
Array ( [id] => 12126509 [patent_doc_number] => 20180010095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'T Cells with Increased Immunosuppression Resistance' [patent_app_type] => utility [patent_app_number] => 15/713464 [patent_app_country] => US [patent_app_date] => 2017-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13533 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15713464 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/713464
T cells with increased immunosuppression resistance Sep 21, 2017 Issued
Array ( [id] => 14578493 [patent_doc_number] => 20190216855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => METHOD OF TARGETING ONCOLYTIC VIRUSES TO TUMORS [patent_app_type] => utility [patent_app_number] => 16/330858 [patent_app_country] => US [patent_app_date] => 2017-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8421 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330858 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/330858
Method of targeting oncolytic viruses to tumors Sep 18, 2017 Issued
Array ( [id] => 17814307 [patent_doc_number] => 11419894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-23 [patent_title] => Modified natural killer cells for the treatment of cancer [patent_app_type] => utility [patent_app_number] => 16/332981 [patent_app_country] => US [patent_app_date] => 2017-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18278 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332981 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/332981
Modified natural killer cells for the treatment of cancer Sep 14, 2017 Issued
Array ( [id] => 14045773 [patent_doc_number] => 20190078993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-14 [patent_title] => Method of Characterization of Exosomes [patent_app_type] => utility [patent_app_number] => 15/703216 [patent_app_country] => US [patent_app_date] => 2017-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3698 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703216 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/703216
Method of characterization of exosomes Sep 12, 2017 Issued
Menu